Stock Taper
MEDP
MEDPACE HOLDINGS, INC.
NASDAQ
$593.39
▲ UP 0.06% (0.37)

KEY STATISTICS

Market Cap$16.53 B
52w High$677.90
52w Low$373.00
Dividend Yield
Frequency
P/E34.78
Volume143.23K
Shares Out.27.91M

COMPANY

LEADERSHIP

August James Troendle
CHIEF EXECUTIVE
August James Troendle

COMPENSATION 2026

Salary$937,417
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$14,000
Total$11,443,766

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 11, 2016
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6,500

PRICE TARGET

Target High$692.00
Target Low$515.00
Target Median$610.00
Target Consensus$606.38

UPCOMING EARNINGS

DateOct 28, 2026
DayWednesday
Rev. Est.$714.27M
OCT
28
WED

PRICE

$593.39 ▲ UP 0.06% (+$0.37)
$590$595$6009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM593.39

About Medpace Holdings, Inc.

https://www.medpace.com ↗

Medpace Holdings, Inc. provides comprehensive clinical research services across all phases for pharma, biotech, and medical device industries worldwide, including development, regulatory, data management, and laboratory support.

INDUSTRY

Medical - Diagnostics & Research

A SERVICE MEDPACE HOLDINGS, INC. IS KNOWN FOR

Full-Service Clinical Research Services

Medpace is a global CRO offering comprehensive clinical development services from Phase I to IV, including study design, patient recruitment, regulatory submissions, and data management for biotech, pharma, and medical device companies.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Metabolic$199.26M $249.81M $237.56M $219.07M
Oncology$192.63M $195.92M $201.24M $209.37M
Other$106.4M $88.25M $93.32M $98.28M
Central Nervous System$65.63M $73.18M $80.21M $82.86M
Cardiology$59.47M $63.04M $56.26M $59.98M
Antiviral And Anti Infective$36.52M $38.25M $38.02M $37.77M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
David Taylor
David Taylor
Purchase
2026-05-15
Gilbert Cisneros
Gilbert Cisneros
Sale (Full)
2026-01-15
Lisa McClain
Lisa McClain
Sale
2025-08-04
Josh Gottheimer
Josh Gottheimer
Sale (Partial)
2024-07-26

INSIDER TRADES

DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT & CEO
Troendle August J.
Sale · 650 shares
2026-08-27
DIRECTOR
Kraft Robert O.
Purchase · 3.9K shares
2026-08-26
DIRECTOR
Kraft Robert O.
Sale · 3.9K shares
2026-08-26
DIRECTOR, 10 PERCENT OWNER, OFFICER: PRESIDENT & CEO
Troendle August J.
Sale · 673 shares
2026-08-25

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 3
MARKET PERFORM 2
OUTPERFORM 2
NEUTRAL 1
EQUAL WEIGHT 1
9 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
CNC$68.03COMPARE
ILMN$215.99COMPARE
WAT$411.90COMPARE
DGX$237.28COMPARE
WST$341.98COMPARE
THC$263.89COMPARE
ICLR$162.21COMPARE
SNN$28.66COMPARE